Why Should Pharma and Biotech Consider Spain for their Cancer Clinical Trials?

Patricio Ledesma

Head Of Clinical Operations at Sofpromed

13 February, 2019

Spain is a great country to conduct clinical trials.

By the end of 2018, according to ClinicalTrials.gov, the American database of clinical studies carried out worldwide, Spain is the fifth European country (taking into account the United Kingdom) with more clinical studies (11,164), very near to the fourth recruiter: Italy (11,387 studies).

In 2018 only, 716 new studies were started in Spanish sites by November, taking Spain up to the fourth position in the European ranking of top recruiters.

The prediction is that this tendency will be consolidated in the future since pharmaceutical and biotechnology sponsors see Spain as an increasingly attractive territory for oncology trials.

Spain attracts US-based and European cancer trial sponsors for various reasons.

Why is Spain a highly appealing country to perform clinical trials in oncology? These are the main advantages:

  1. The high number of clinical studies conducted in Spanish hospitals
  2. The growing interest of multinational pharmaceutical companies
  3. The constant growth of clinical trials in the early stages
  4. More clinical trials in rare diseases
  5. The early adoption of European clinical trial legislation
  6. Short study start-up timelines
  7. The quality of Spanish healthcare, science, and professionals
  8. The large number of oncology trials
  9. The strategic role of national cooperative cancer research groups

Would you like to see a more detailed explanation of these aspects one by one? Read the whole guide:

In this guide you can read a comprehensive explanation of the scientific and operational advantages of conducting clinical trials in Spanish hospitals, including very valuable recommendations for sponsors planning oncology studies.

Patricio Ledesma

Patricio Ledesma (B.Eng Concordia University, Montreal, Canada and Master’s Degree in Clinical Trials, University of Seville, Spain) is the Head of Clinical Operations and Founder at Sofpromed CRO. Patricio is a professional consultant providing comprehensive, one-stop expert advice and guidance to biotechnology and pharmaceutical companies worldwide in the field of clinical trials and drug development. He is personally and enthusiastically devoted to helping biotech Chief Executive, Operations, Scientific, Medical, and Regulatory Officers in the planning and execution of phase I-IV clinical trials across North America, Europe, Asia-Pacific, Latin America, and Middle East regions. You can contact Patricio at: +34 607 939 266  pledesma@sofpromed.com 

You may also be interested…

Medical Monitors for Clinical Trials in Europe

Medical Monitors for Clinical Trials in Europe

If you need to hire Medical Monitors for clinical trials in Europe, please contact us at info@sofpromed.com  The importance of hiring dedicated Medical Monitors to conduct clinical trials lies in the fact that they provide safety oversight to scientific research...

Viedoc: The EDC Solution for Oncology Clinical Trials

Viedoc: The EDC Solution for Oncology Clinical Trials

For more information about the Viedoc EDC solution, please contact us at info@sofpromed.com Oncology clinical trials are complex and require the use of effective Electronic Data Capture (EDC) tools to ensure high-quality data collection, cleaning, and analysis. As a...

How to Prepare for an FDA Clinical Site Inspection

How to Prepare for an FDA Clinical Site Inspection

Contact info@sofpromed.com to learn more about how to prepare for an FDA clinical site inspection   You are a hospital or clinic participating in a clinical trial and one day two officers from the US Food and Drug Administration (FDA) arrive at your facility...

Patricio Ledesma

Patricio Ledesma (B.Eng Concordia University, Montreal, Canada and Master’s Degree in Clinical Trials, University of Seville, Spain) is the Head of Clinical Operations and Founder at Sofpromed CRO. Patricio is a professional consultant providing comprehensive, one-stop expert advice and guidance to biotechnology and pharmaceutical companies worldwide in the field of clinical trials and drug development. He is personally and enthusiastically devoted to helping biotech Chief Executive, Operations, Scientific, Medical, and Regulatory Officers in the planning and execution of phase I-IV clinical trials across North America, Europe, Asia-Pacific, Latin America, and Middle East regions. You can contact Patricio at: +34 607 939 266 pledesma@sofpromed.com